V003-0427 Screening compound: 1-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl}-3-(1H-indol-3-yl)-3-(4-methoxyphenyl)propan-1-one

V003-0427 Screening compound: 1-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl}-3-(1H-indol-3-yl)-3-(4-methoxyphenyl)propan-1-one
V003-0427 Screening compound: 1-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl}-3-(1H-indol-3-yl)-3-(4-methoxyphenyl)propan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound V003-0427
1-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl}-3-(1H-indol-3-yl)-3-(4-methoxyphenyl)propan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V003-0427

Molecular Formula

C30H31N3O4 (C30 H31 N3 O4)

Compound Name

1-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl}-3-(1H-indol-3-yl)-3-(4-methoxyphenyl)propan-1-one

IUPAC name

1-{4-[(2H-13-benzodioxol-5-yl)methyl]piperazin-1-yl}-3-(1H-indol-3-yl)-3-(4-methoxyphenyl)propan-1-one

SMILES

COc1ccc(C(CC(N2CCN(Cc(cc3)cc4c3OCO4)CC2)=O)c2c[nH]c3c2cccc3)cc1

InChI

InChI=1S/C30H31N3O4/c1-35-23-9-7-22(8-10-23)25(26-18-31-27-5-3-2-4-24(26)27)17-30(34)33-14-12-32(13-15-33)19-21-6-11-28-29(16-21)37-20-36-28/h2-11,16,18,25,31H,12-15,17,19-20H2,1H3/t25-/m1/s1

InChI Key

LAQAHTCLQLXAIN-RUZDIDTESA-N

MDL Number (MFCD)

MFCD19850781

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

497.59

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.440

Distribution Coefficient, logD

4.096

Water Solubility, LogSw

-4.26

Polar Surface Area

54.158

Acid Dissociation Constant (pKa)

17.49

Base Dissociation Constant (pKb)

7.48

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

30.00

V003-0427 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

Indole Derivatives (10091 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with V003-0427 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V003-0427?
Check Price and Availability of V003-0427, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V003-0427 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V003-0427
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V003-0427
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V003-0427 available by request